These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1748434

  • 21. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
    Chariot P, Bonne G, Authier FJ, Marsac C, Gherardi R.
    J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166
    [Abstract] [Full Text] [Related]

  • 22. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model.
    Lamperth L, Dalakas MC, Dagani F, Anderson J, Ferrari R.
    Lab Invest; 1991 Dec; 65(6):742-51. PubMed ID: 1753716
    [Abstract] [Full Text] [Related]

  • 23. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations.
    Cupler EJ, Danon MJ, Jay C, Hench K, Ropka M, Dalakas MC.
    Acta Neuropathol; 1995 Dec; 90(1):1-6. PubMed ID: 7572071
    [Abstract] [Full Text] [Related]

  • 24. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
    Morgello S, Wolfe D, Godfrey E, Feinstein R, Tagliati M, Simpson DM.
    Acta Neuropathol; 1995 Dec; 90(4):366-74. PubMed ID: 8546027
    [Abstract] [Full Text] [Related]

  • 25. [Assessment of mitochondrial toxicity induced by zidovudine and adefovir dipivoxil in rats].
    Zhu B, Zhu ZN, Wang JZ, Huang SM, Feng XM, Li AY, Yang DL, Wang BJ.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):794-7. PubMed ID: 23207344
    [Abstract] [Full Text] [Related]

  • 26. AZT-induced mitochondrial myopathy.
    Tomelleri G, Tonin P, Spadaro M, Tilia G, Orrico D, Barelli A, Bonetti B, Monaco S, Salviati A, Morocutti C.
    Ital J Neurol Sci; 1992 Dec; 13(9):723-8. PubMed ID: 1336487
    [Abstract] [Full Text] [Related]

  • 27. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion.
    Chariot P, Drogou I, de Lacroix-Szmania I, Eliezer-Vanerot MC, Chazaud B, Lombès A, Schaeffer A, Zafrani ES.
    J Hepatol; 1999 Jan; 30(1):156-60. PubMed ID: 9927163
    [Abstract] [Full Text] [Related]

  • 28. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.
    Herzberg NH, Zorn I, Zwart R, Portegies P, Bolhuis PA.
    Muscle Nerve; 1992 Jun; 15(6):706-10. PubMed ID: 1324428
    [Abstract] [Full Text] [Related]

  • 29. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM, Citak KA, Godfrey E, Godbold J, Wolfe DE.
    Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
    [Abstract] [Full Text] [Related]

  • 30. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A.
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [Abstract] [Full Text] [Related]

  • 31. Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy.
    Sinnwell TM, Sivakumar K, Soueidan S, Jay C, Frank JA, McLaughlin AC, Dalakas MC.
    J Clin Invest; 1995 Jul; 96(1):126-31. PubMed ID: 7615782
    [Abstract] [Full Text] [Related]

  • 32. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells.
    d'Amati G, Lewis W.
    Lab Invest; 1994 Dec; 71(6):879-84. PubMed ID: 7528833
    [Abstract] [Full Text] [Related]

  • 33. Nuclear and mitochondrial changes of co-cultivated spinal cord, spinal ganglia and muscle fibers following treatment with various doses of zidovudine.
    Schröder JM, Kaldenbach T, Piroth W.
    Acta Neuropathol; 1996 Aug; 92(2):138-49. PubMed ID: 8841659
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Skeletal muscle mitochondria from AZT-treated rats have a diminished response to chronic electrical stimulation.
    McCurdy DT, Kennedy JM.
    J Appl Physiol (1985); 1996 Jul; 81(1):326-34. PubMed ID: 8828681
    [Abstract] [Full Text] [Related]

  • 36. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
    Espinoza LR, Aguilar JL, Espinoza CG, Gresh J, Jara J, Silveira LH, Martinez-Osuna P, Seleznick M.
    Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882
    [Abstract] [Full Text] [Related]

  • 37. Zidovudine [AZT] myotoxicity: quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus.
    Waclawik AJ, Vann J, Schmelz G, Szurek P, Lewandoski P, Brooks BR.
    Neurotoxicology; 1999 Feb; 20(1):49-56. PubMed ID: 10091858
    [Abstract] [Full Text] [Related]

  • 38. Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes.
    Cazzalini O, Lazzè MC, Iamele L, Stivala LA, Bianchi L, Vaghi P, Cornaglia A, Calligaro A, Curti D, Alessandrini A, Prosperi E, Vannini V.
    Biochem Pharmacol; 2001 Oct 01; 62(7):893-902. PubMed ID: 11543724
    [Abstract] [Full Text] [Related]

  • 39. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK.
    Neuropathol Appl Neurobiol; 1994 Jun 01; 20(3):232-7. PubMed ID: 7936072
    [Abstract] [Full Text] [Related]

  • 40. HIV or zidovudine myopathy?
    Grau JM, Casademont J.
    Neurology; 1994 Feb 01; 44(2):361; author reply 362-4. PubMed ID: 8309595
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.